Originally published as JHC exPRESS on September 6, 2007. doi:10.1369/jhc.7A7232.2007
Volume 55 (12): 1237-1244, 2007 Copyright ©The Histochemical Society, Inc. Expression of Prostasin Serine Protease and Protease Nexin-1 (PN-1) in Rhesus Monkey Ovary During Menstrual Cycle and Early Pregnancy
State Key Laboratory of Reproductive Biology, Institute of Zoology (HZ,H-YL,QY,H-XW,CZ) and Graduate School (HZ,QY), Chinese Academy of Sciences, Beijing, People's Republic of China, and Department of Molecular Biology and Microbiology (KXC,L-MC) and Biomolecular Science Center (KXC), University of Central Florida, Orlando, Florida Correspondence to: Cheng Zhu, State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Datun Road, Chaoyang District, Beijing 100101, People's Republic of China. E-mail: zhuc{at}ioz.ac.cn
Serine proteases and their cognate serpin-class inhibitors are involved in the controlled proteolytic events during follicular development, ovulation, formation, and maintenance of the corpus luteum (CL). In this study, we investigated the expression patterns of prostasin serine protease and protease nexin-1 (PN-1), a serine protease inhibitor also called serpin-E2, in rhesus monkey ovaries during the menstrual cycle and early pregnancy, by using in situ hybridization and immunohistochemistry. Expression of prostasin was localized in oocyte, granulosa cells, and/or theca cells of early antral follicles and antral follicles, with high levels observed in preovulatory follicles. Prostasin was also localized at high levels of abundance in the CL during the menstrual cycle and early pregnancy. During the menstrual cycle, PN-1 was coordinately localized with prostasin in oocytes, granulosa cells, and theca cells of antral follicles and preovulatory follicles and in the CL. In addition, the PN-1 expression level in macaque CL during early pregnancy increased as pregnancy proceeded. We propose that prostasin may be involved in follicular development, ovulation, and CL formation, whereas PN-1 may be present to regulate the proteolysis in these processes. (J Histochem Cytochem 55:1237–1244, 2007)
Key Words: prostasin protease nexin-1 ovary primate
DRAMATIC TISSUE DEGRADATION and remodeling take place during follicular development, ovulation, formation, and regression of the corpus luteum (CL). These processes are characterized by tightly controlled proteolysis and a balance between proteases and protease inhibitors, including the serine proteases and their cognate inhibitors. Serine proteases, which use the side-chain hydroxyl group to attack the target peptide, form the largest family of mammalian proteases (Salamonsen 1999
Prostasin serine protease, with a molecular mass of 40 kDa, has a glycosylphosphatidyl inositol membrane anchor and can also be secreted (Yu et al. 1994
A prostasin-binding protein abundant in the seminal vesicles has recently been identified as protease nexin-1 (PN-1), which inhibits the activity of prostasin and can bind to membrane-anchored prostasin (Chen et al. 2004 In this study, as a first step toward understanding the potential roles of prostasin and PN-1 in the primate ovary, we investigated the distribution patterns of prostasin and PN-1 transcripts and proteins in the rhesus monkey ovary during the menstrual cycle and early pregnancy, by using in situ hybridization and immunohistochemistry.
Animals and Tissue Preparation Animal care and treatment were in agreement with the Guidelines on the Care and Use of Laboratory Animals of the Ethical Committee, State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences. Rhesus monkeys (Macaca mulatta) were housed in the Medical Primate Center, Institute of Medical Biology, Chinese Academy of Medical Sciences as detailed previously (Wang et al. 2001
Probes Synthesis
A full-length human PN-1 cDNA was amplified by PCR as described previously (Chen et al. 2004 The concentrations of the riboprobes were determined using MetaView image analyzing system version 4.50 (Universal Imaging Corp.; Downingtown, PA) on spot tests following the manufacturer's instructions, with a DIG-labeled RNA control provided in the labeling kit.
In Situ Hybridization
Immunohistochemistry
Statistical Analysis
Localization of Prostasin and PN-1 mRNA in Macaque Ovarian Tissue During the Menstrual Cycle In situ hybridization was performed to study the spatiotemporal expression patterns of prostasin and PN-1 mRNA in the cyclic macaque ovary. Prostasin mRNA was concentrated in oocytes and granulosa cells of early antral follicles at high levels (p<0.01; Figure 1 ; Table 1 ), whereas signals in theca cells were not different from background staining (p>0.05; Figure 1; Table 1). In the early antral follicles, the PN-1 transcript was expressed in oocytes and granulosa cells at a moderate level (p<0.05; Figure 1; Table 1), and signal in theca cells was the same as the background (p>0.05). In the granulosa cells and theca cells of developing antral follicles, both prostasin and PN-1 were strongly expressed (p<0.01; Figure 1; Table 1). Prostasin and PN-1 were also expressed in the stroma at this stage. In preovulatory follicles, prostasin and PN-1 were localized in oocytes, granulosa cells, theca cells, and the stroma at high levels (p<0.01; Figure 1; Table 1), and the signals at this stage were the strongest compared with those at other stages of folliculogenesis. In the CL, prostasin was expressed in the CL at high levels and in the stroma at moderate levels. A strong PN-1 signal was observed both in the CL and stroma (p<0.01; Figure 1; Table 1). Sense-strand probes for prostasin and PN-1 yielded no specific signal in any tissues studied (Figure 1).
Immunohistochemical Staining of Prostasin and PN-1 in Rhesus Monkey Ovaries During the Menstrual Cycle To localize prostasin and PN-1 proteins in the cyclic ovary, immunohistochemical staining was performed. The results showed that the expression levels of prostasin and PN-1 proteins in granulosa cells and theca cells increased from background levels (p>0.05) to high levels (p<0.01) along with follicle development from early antral follicles to preovulatory follicles. However, prostasin and PN-1 proteins were highly expressed in oocytes from early antral follicles to preovulatory follicles (p<0.01; Figure 2 ; Table 2 ) and also were expressed in the stroma at moderate or high levels. In the CL, prostasin protein was highly expressed in the CL (p<0.01) and moderately expressed in the stroma (p<0.05; Figure 2; Table 2). PN-1 protein was only moderately expressed in the CL. The negative control treated with normal rabbit IgG produced negligible background (Figure 2).
Localization of Prostasin and PN-1 mRNA in Macaque Ovarian Tissue During Early Pregnancy As shown in Figure 3 and Table 3 , relatively strong signals of prostasin transcripts were localized in the CL in the macaque ovary on days 12, 18, and 26 of early pregnancy (p<0.01). Distinct from the expression pattern of prostasin, PN-1 was moderately expressed in the CL on day 12 of pregnancy (p<0.05), strongly expressed on day 18, and peaked on day 26 (p<0.01; Figure 3; Table 3). The intensity of PN-1 mRNA in the CL significantly increased over the three stages of pregnancy (p<0.05; Table 3). No background staining was detected in control tissues hybridized with sense probes (Figure 3).
Immunohistochemical Staining of Prostasin and PN-1 in Rhesus Monkey Ovaries During Early Pregnancy As shown in Figure 4 and Table 4 , high levels of prostasin protein signals were observed in the CL in the monkey ovary on days 12, 18, and 26 of early pregnancy (p<0.01; Figure 4; Table 4). PN-1 protein was expressed in the CL at a relatively low concentration on day 12 of pregnancy (p<0.05; Figure 4; Table 4). The signals of PN-1 peaked on day 18 and kept a high level of expression on day 26 (p<0.01; Figure 4; Table 4). Control sections stained with normal rabbit IgG produced no positive signal (Figure 4).
In this study, we reported the expression of prostasin during macaque follicular development and CL formation in the menstrual cycle and early pregnancy. Ovarian follicles and the CL undergo striking tissue remodeling involving multiple proteolytic events, during which serine proteases of plasminogen activation cascade have been shown to play crucial roles (Hagglund et al. 1996
Many lines of evidence exist to show that PN-1 is involved in controlled proteolysis during ovarian tissue remodeling. PN-1 is expressed at the highest level in granulosa cells of growing dominant bovine follicles (Bedard et al. 2003
Study on the distribution pattern of PN-1 in the macaque CL during early pregnancy led to the revelation of a progressive increase of PN-1 expression as pregnancy proceeded. A report on rats (Kim et al. 2001
Because of the fact that proteolysis during follicular development, ovulation, and CL development has to be spatiotemporally restricted, the fine-tuned balance between the levels of protease and inhibitor is important to the control of tissue growth and remodeling. Earlier studies have showed that mouse granulosa cells express low levels of PN-1 and high levels of uPA, whereas cumulus cells express high levels of PN-1 and low levels of uPA, and these heterogeneous and complementary expression patterns for PN-1 and uPA provide the basis for regulation of proteolytic activity around the cumulus–oocyte complex (Hagglund et al. 1996 In conclusion, we showed that prostasin serine protease is expressed in a pattern that is consistent with a role in matrix degradation and remodeling during follicular development, ovulation, and CL formation. PN-1 may be involved in controlled proteolysis in these processes by regulating the activity of prostasin, as suggested by its specific pattern of expression.
This study was supported by the Knowledge Innovation Program of Chinese Academy of Sciences (KSCX3-IOZ-07), the Department of Defense Prostate Cancer Research Program (to KXC, Grant DAMD17-02-1-0032), and the National Institutes of Health (to L-MC, Grant HD 40241).
Received for publication May 7, 2007; accepted August 14, 2007
Bedard J, Brule S, Price CA, Silversides DW, Lussier JG (2003) Serine protease inhibitor-E2 (SERPINE2) is differentially expressed in granulosa cells of dominant follicle in cattle. Mol Reprod Dev 64:152–165[CrossRef][Medline] Bhagwandin VJ, Hau LWT, Clair JMS, Wolters PJ, Caughey GH (2003) Structure and activity of human pancreasin, a novel tryptic serine peptidase expressed primarily by the pancreas. J Biol Chem 278:3363–3371 Cao M, Sahmi M, Lussier JG, Price CA (2004) Plasminogen activator and serine protease inhibitor-E2 (protease nexin-1) expression by bovine granulosa cells in vitro. Biol Reprod 71:887–893 Chen LM, Chai KX (2002) Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter DNA methylation. Int J Cancer 97:323–329[CrossRef][Medline] Chen LM, Hodge GB, Guarda LA, Welch JL, Greenberg NM, Chai KX (2001a) Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancer. Prostate 48:93–103[CrossRef][Medline] Chen LM, Skinner ML, Kauffman SW, Chao J, Chao L, Thaler CD, Chai KX (2001b) Prostasin is a glycosylphosphatidylinositol-anchored active serine protease. J Biol Chem 276:21434–21442 Chen LM, Zhang X, Chai KX (2004) Regulation of prostasin expression and function in the prostate. Prostate 59:1–12[CrossRef][Medline] Clements J, Mukhtar A, Yan S, Holland A (1997) Kallikreins and kinins in inflammatory-like events in the reproductive tract. Pharmacol Res 35:537–540[CrossRef][Medline] Diamandis EP, Yousef GM (2002) Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem 48:1198–1205 Gettins PG (2002) Serpin structure, mechanism, and function. Chem Rev 102:4751–4804[CrossRef][Medline] Hagglund AC, Ny A, Liu K, Ny T (1996) Coordinated and cell-specific induction of both physiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulation. Endocrinology 137:5671–5677[Abstract] Hasan S, Hosseini G, Princivalle M, Dong JC, Birsan D, Cagide C, de Agostini AI (2002) Coordinate expression of anticoagulant heparan sulfate proteoglycans and serine protease inhibitors in the rat ovary: a potent system of proteolysis control. Biol Reprod 66:144–158 Iwashita K, Kitamura K, Narikiyo T, Adachi M, Shiraishi N, Miyoshi T, Nagano J, et al. (2003) Inhibition of prostasin secretion by serine protease inhibitors in the kidney. J Am Soc Nephrol 14:11–16 Kim NK, Choi MJ, Chung HM, Sohn TJ, Hwang SG, Oh D, Lee HH, et al. (2001) Increased expression and localization of a serine protease inhibitor, protease nexin-1 (PN-1), in the ovary and uterus during implantation in rat. Thromb Res 103:135–142[CrossRef][Medline] Lin HY, Zhang H, Yang Q, Wang HX, Wang HM, Chai KX, Chen LM, et al. (2006) Expression of prostasin and protease nexin-1 in rhesus monkey (Macaca mulatta) endometrium and placenta during early pregnancy. J Histochem Cytochem 54:1139–1147 Liu K, Brandstrom A, Liu YX, Ny T, Selstam G (1996) Coordinated expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 during corpus luteum formation and luteolysis in the adult pseudopregnant rat. Endocrinology 137:2126–2132[Abstract] Liu YX (2004) Plasminogen activator/plasminogen activator inhibitors in ovarian physiology. Front Biosci 9:3356–3373[CrossRef][Medline] Narikiyo T, Kitamura K, Adachi M, Miyoshi T, Iwashita K, Shiraishi N, Nonoguchi H, et al. (2002) Regulation of prostasin by aldosterone in the kidney. J Clin Invest 109:401–408[CrossRef][Medline] Ny T, Wahlberg P, Brandstrom IJ (2002) Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinase systems. Mol Cell Endocrinol 187:29–38[CrossRef][Medline] Salamonsen LA (1999) Role of proteases in implantation. Rev Reprod 4:11–22[Abstract] Scott RW, Bergman BL, Bajpai A, Hersh RT, Rodriguez H, Jones BN, Barreda C, et al. (1985) Protease Nexin. Properties and a modified purification procedure. J Biol Chem 260:7029–7034 Takahashi S, Suzuki S, Inaguma S, Ikeda Y, Cho YM, Hayashi N, Inoue T, et al. (2003) Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers. Prostate 54:187–193[CrossRef][Medline] Tuyen DG, Kitamura K, Adachi M, Miyoshi T, Wakida N, Nagano J, Nonoguchi H, et al. (2005) Inhibition of prostasin expression by TGF-beta1 in renal epithelial cells. Kidney Int 67:193–200[CrossRef][Medline] Wang HM, Li QL, Shao LJ, Zhu C (2001) Expression of matrix metalloproteinase-2, -9, -14, and tissue inhibitors of metalloproteinase-1, -2, -3 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy. Biol Reprod 65:31–40 Wang HX, Wang HM, Li QL, Lin HY, Qian D, Zhu C (2004) Expression of proteasome subunits low molecular mass polypeptide (LMP) 2 and LMP7 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy. Biol Reprod 71:1317–1324 Yu JX, Chao L, Chao J (1994) Prostasin is a novel human serine proteinase from seminal fluid. Purification, tissue distribution, and localization in prostate gland. J Biol Chem 269:18843–18848
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||